All companies › TLSI

TLSI · TriSalus Life Sciences, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells3
Research cases0
Last filing2026-10-05

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-10-05 — Stevens Jennifer · sold 316 @ $4.39 2026-10-05 — Marshak Richard · sold 325 @ $4.39 2026-10-05 — Cox Bryan F. · sold 296 @ $4.39
2026-10-052026-10-05

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Stevens Jennifer Chief Regulatory Officer
Marshak Richard Chief Commercial Officer
Cox Bryan F. Chief of Research
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $TLSI is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-05', 'insider_name': 'Stevens Jennifer', 'insider_title': 'Chief Regulatory Officer', 'transaction_type': 'Open-market sell', 'shares': 316.0, 'price': 4.39, 'value': 1387.24, 'is_buy': False}, {'transaction_date': '2026-10-05', 'insider_name': 'Marshak Richard', 'insider_title': 'Chief Commercial Officer', 'transaction_type': 'Open-market sell', 'shares': 325.0, 'price': 4.39, 'value': 1426.75, 'is_buy': False}, {'transaction_date': '2026-10-05', 'insider_name': 'Cox Bryan F.', 'insider_title': 'Chief of Research', 'transaction_type': 'Open-market sell', 'shares': 296.0, 'price': 4.39, 'value': 1299.44, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for TLSI today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.